Forte Biosciences FBRX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 15.00 | 103.96 | -0.94 | -18,383 | -18 | |
| 2025Q2 | 12.93 | 102.93 | -0.95 | -11,579 | -11 | |
| 2025Q1 | 7.76 | 102.99 | -1.37 | -16,124 | -16 | |
| 2024Q4 | 22.71 | 102.74 | 3.18 | -7,351 | -7 | |
| 2024Q3 | 5.59 | 102.82 | -4.54 | -8,629 | -8 | |
| 2024Q2 | 13.43 | 102.45 | -6.78 | -12,818 | -13 | |
| 2024Q1 | 17.41 | 105.18 | -4.03 | -7,804 | -7 | |
| 2023Q4 | 20.54 | 108.67 | -0.95 | -6,381 | -6 | |
| 2023Q3 | 16.55 | 102.62 | -5.47 | -10,216 | -10 | |
| 2023Q2 | 26.00 | 101.55 | -10.50 | -9,034 | -9 | |
| 2023Q1 | 25.25 | 101.51 | -8.00 | -6,855 | -7 | |
| 2022Q4 | 25.00 | 101.27 | -6.00 | -4,939 | -5 | |
| 2022Q3 | 26.75 | 100.68 | -4.50 | -3,423 | -3 | |
| 2022Q2 | 32.50 | 99.51 | -5.25 | -3,020 | -3 | |
| 2022Q1 | 36.50 | 97.94 | -4.25 | -2,514 | -3 | |
| 2021Q4 | 53.50 | 98.74 | -5.25 | -3,299 | -3 | |
| 2021Q3 | 74.00 | 99.33 | -13.75 | -7,699 | -8 | |
| 2021Q2 | 840.50 | 98.88 | -10.75 | -5,747 | -6 | |
| 2021Q1 | 856.75 | 98.69 | -9.00 | -4,741 | -5 | |
| 2020Q4 | 910.25 | 98.19 | 26.00 | -4,493 | -5 |